Measuring vaccine effectiveness against persistent HPV infections: a comparison of different statistical approaches

BACKGROUND: Persistent high-risk human papillomavirus (HPV) infection is endorsed by the World Health Organization as an intermediate endpoint for evaluating HPV vaccine effectiveness/efficacy. There are different approaches to estimate the vaccine effectiveness/efficacy against persistent HPV infec...

Descripción completa

Detalles Bibliográficos
Autores principales: Donken, R., Hoes, J., Knol, M. J., Ogilvie, G. S., Dobson, S., King, A. J., Singer, J., Woestenberg, P. J., Bogaards, J. A., Meijer, C. J. L. M., de Melker, H. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341660/
https://www.ncbi.nlm.nih.gov/pubmed/32640998
http://dx.doi.org/10.1186/s12879-020-05083-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341660/
https://www.ncbi.nlm.nih.gov/pubmed/32640998
http://dx.doi.org/10.1186/s12879-020-05083-7

Ejemplares similares